Universal Health Services (UHS)
(Delayed Data from NYSE)
$233.14 USD
+3.85 (1.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $233.11 -0.03 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$233.14 USD
+3.85 (1.68%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $233.11 -0.03 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value A Growth D Momentum A VGM
Zacks News
How to Invest After the Market Selloff
by Sejuti Banerjea
Tried and tested methods always work best when you're faced with increased uncertainty and volatility.
Impressive Sales Growth Makes These 5 Stocks Worth Buying
by Swayta Shah
Sales growth is an important indicator of a company's health and ability to sustain the business.
Why Is Universal Health Services (UHS) Up 0.6% Since Last Earnings Report?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG) Continues to Gain From Buyout Binge
by Zacks Equity Research
Ensign Group's (ENSG) series of buyouts poise it well for growth by enhancing its capabilities, both financially and clinically.
Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q2 earnings results reflect better revenues from its Transitional and Skilled Services segment.
Humana's (HUM) Q2 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) Q2 earnings reflect better revenues and solid contributions from its Retail and Healthcare Services segments.
Tenet Healthcare (THC) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q2 earnings gain from operational performance, partly offset by lower revenues.
Select Medical's (SEM) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Select Medical's (SEM) second-quarter earnings performance benefits from lower expenses.
MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.
Teladoc (TDOC) Q2 Earnings Lag Estimates, Revenues Up Y/Y
by Zacks Equity Research
Teladoc's (TDOC) second-quarter results reflect higher revenues and solid rise in patient visits, partially offset by increased expenses.
Anthem (ANTM) Q2 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q2 results reflect higher premium revenues and a solid contribution from Government business.
Community Health (CYH) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Community Health's (CYH) second-quarter results reflect lower costs, partially offset by softer revenues owing to decline in admissions.
Universal Health (UHS) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings reflect lower expenses, partially offset by reduced patient volumes.
Universal Health Services (UHS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 463.46% and 12.41%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Universal Health (UHS) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.
Is a Surprise Coming for Universal Health Services (UHS) This Earnings Season?
by Zacks Equity Research
Universal Health Services (UHS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to reflect dented revenues due to the pandemic woes.
Universal Health Services (UHS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Healthcare Opens Mental Health Unit With Tower Health
by Zacks Equity Research
Acadia Healthcare (ACHC) unveils a facility to fortify its foothold in the mental health and behavioral healthcare market.
Here's Why You Should Steer Clear of MEDNAX (MD) at Present
by Zacks Equity Research
Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.
Tenet Healthcare Plunges 55.7% YTD: Will the Stock Rebound?
by Zacks Equity Research
Even though Tenet Healthcare (THC) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its endeavors and strong fundamentals.
Here's Why You Should Steer Clear of HCA Healthcare Now
by Zacks Equity Research
Elevated expenses and muted revenues due to coronavirus pandemic make HCA Healthcare (HCA) an unattractive bet.
Community Health to Sell Unit for Streamlining Operations
by Zacks Equity Research
Community Health (CYH) is set to sell hospital units for debt-reduction and business rejig.
Court Ruling on Price Transparency Unsettles Hospital Stocks
by Sapna Bagaria
Stocks of most hospital companies take a hit after the federal court retains the rules pertaining to pricing transparency.